Charta Health Raises $55M Series B for AI-Powered Chart Review
Charta Health, a San Francisco-based company that uses artificial intelligence for medical chart reviews, has raised $55 million in a Series B funding round.1
By Victoria Shi · AI Funding Reporter Nov 13, 2026

The round was led by Insight Partners, with participation from existing investors Madrona, Bain Capital Ventures, and South Park Commons, as well as new investor QuantumLight, according to multiple reports. The new capital brings Charta Health’s total funding to $85 million, according to PR Newswire and other outlets.1,2
Charta Health provides an AI-powered platform that performs autonomous pre-bill reviews of medical charts to automate outpatient coding, discover revenue, and ensure payer compliance, according to Clinical Terminal data. The company states its platform analyzes clinical documentation to identify and correct coding errors, aiming to reduce disputes between providers and payers, as reported by Finsmes. Charta advertises 98% accuracy for diagnosis coding by combining its AI with human validation, according to Unite.AI.1,5,6
The company will use the new capital to accelerate its AI research and development and to launch two new service lines, "Charta for Providers" and "Charta for Payers," PR Newswire reported. The company also reported that its revenue grew 10 times in the last 12 months.2
Charta Health was founded in 2023 by CEO Justin Liu and CTO Scott Morris, who were previously engineering leaders at the database and analytics company Rockset, according to HIT Consultant. The Series B round follows a $22 million Series A in July 2025, as reported by BHBusiness and Dealroom.co.3,4
Charta’s clients include American Family Care, Grow Therapy, and Pediatric Associates Family of Companies, according to a press release.2